US Patent 8273360 Outer membrane vesicle (OMV) vaccine comprising

Patent 8273360 was granted and assigned to Novartis on September, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Novartis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

82733600

Patent Inventor Names

Mariagrazia Pizza0

Marzia Monica Giuliani0

Rino Rappuoli0

Date of Patent

September 25, 2012

Patent Application Number

101816000

Date Filed

January 17, 2001

Patent Citations Received

‌

US Patent 11801293 GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by

‌

US Patent 11680087 None

Patent Primary Examiner

‌

S. Devi

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8273360 Outer membrane vesicle (OMV) vaccine comprising

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API